Latest Articles

Publication Date
All News Scientific
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - MSN

‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling MSN

Published: April 19, 2025, 1:26 a.m.
Read Full Article
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive

Published: April 18, 2025, 3:54 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - GB News

‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling GB News

Published: April 17, 2025, 11:02 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Role of Lymphadenectomy in the Management of Early-Stage Endometrial Cancer - Cureus

Role of Lymphadenectomy in the Management of Early-Stage Endometrial Cancer Cureus

Published: April 17, 2025, 6:27 a.m.
Read Full Article
Emma Barnett's crucial endometriosis plea: 'Doctors don't have a clue' - Women's Health

Emma Barnett's crucial endometriosis plea: 'Doctors don't have a clue' Women's Health

Published: April 16, 2025, 12:05 p.m.
Read Full Article
Emma Barnett's crucial endometriosis plea: 'Doctors don't have a clue' - Yahoo Life UK

Emma Barnett's crucial endometriosis plea: 'Doctors don't have a clue' Yahoo Life UK

Published: April 16, 2025, 12:01 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!